Eidelman Virant Capital Invo Bioscience, Inc. Transaction History

Eidelman Virant Capital

  • $136 Million
  • Q3 2022

A detailed history of Eidelman Virant Capital transactions in Invo Bioscience, Inc. stock. As of the latest transaction made, Eidelman Virant Capital holds 14,062 shares of INVO stock, worth $11,390. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,062
Previous 14,062 -0.0%
Holding current value
$11,390
Previous $14,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
BUY
$0.64 - $2.66 $1,920 - $7,980
3,000 Added 27.12%
14,062 $14,000
Q1 2022

Apr 12, 2022
BUY
$2.19 - $3.82 $24,225 - $42,256
11,062 New
11,062 $29,000
Q1 2021

Apr 20, 2021
SELL
$2.96 - $9.4 $59,200 - $188,000
-20,000 Closed
0 $0
Q4 2020

Jan 26, 2021
BUY
$3.0 - $9.47 $60,000 - $189,400
20,000 New
20,000 $60,000

Others Institutions Holding INVO

# of Institutions
1
Shares Held
14.1K
Call Options Held
0
Put Options Held
0
View Full List

About INVO Bioscience, Inc.

INVO Quotes by TradingView
  • Ticker INVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,169,700
  • Market Cap $9.86M
  • Description
  • INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More about INVO
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email